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Abstract
Background: Thioredoxin 80 (Trx80) is an 80 amino acid natural cleavage product of Trx, produced primarily by monocytes.
Trx80 induces differentiation of human monocytes into a novel cell type, named Trx80-activated-monocytes (TAMs).
Principal Findings: In this investigation we present evidence for a role of TAMs in the control of intracellular bacterial
infections. As model pathogens we have chosen Listeria monocytogenes and Brucella abortus which replicate in the cytosol
and the endoplasmic reticulum respectively. Our data indicate that TAMs efficiently inhibit intracellular growth of both L.
monocytogenes and B. abortus. Further analysis shows that Trx80 activation prevents the escape of GFP-tagged L.
monocytogenes into the cytosol, and induces accumulation of the bacteria within the lysosomes. Inhibition of the lysosomal
activity by chloroquine treatment resulted in higher replication of bacteria in TAMs compared to that observed in control
cells 24 h post-infection, indicating that TAMs kill bacteria by preventing their escape from the endosomal compartments,
which progress into a highly degradative phagolysosome.
Significance: Our results show that Trx80 potentiates the bactericidal activities of professional phagocytes, and contributes
to the first line of defense against intracellular bacteria.
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Introduction
Monocytes/macrophages constitute one of the first lines of
defense of the innate immune response against infectious agents.
These cells are dedicated to the elimination of infectious microbes
by phagocytosis. Newly formed phagosome containing bacteria
will mature along the endocytic pathway, which culminates in a
highly degradative phagolysosome through fusion with lysosomes
[1]. The maturation process of phagosomes is tightly regulated,
but many intracellular pathogens have developed sophisticated
ways to circumvent phagosomes maturation in order to avoid
destruction and ultimately multiply inside these cells. Such
strategies include rapid escape from the phagosome to access
either: i) the cytosol (Listeria monocytogenes); or ii) the endoplasmic
reticulum (Brucella abortus); and iii) arresting the normal maturation
of the phagosome (Mycobacterium tuberculosis) [2,3,4,5].
Identification of host factors that may regulate survival of
pathogens within macrophages has strong implication for
developing novel therapeutic approaches. In this context, it is
interesting to study the biological properties of thioredoxin (Trx)
80, a truncated form of Thioredoxin (Trx). Trx is a major
intracellular protein-disulfide reductase [6]. Trx80 is an 80 amino
acid natural cleavage product of Trx, produced primarily by
monocytes [7] that was initially described as an eosinophilic
cytotoxicity enhancing factor (ECEF) [8]. Trx80 lacks the c-
terminal ba motif of the thioredoxin fold [9,10] and it is devoid of
the disulfide oxidoreductase activity of thioredoxin. Recombinant
Trx80 evokes proliferation of normal human peripheral blood
mononuclear cells and acts as a chemokine for monocytes, T cells
and polymorphonuclear cells [11].
We have previously demonstrated that Trx80 triggers innate
immunity by inducing the differentiation of human monocytes into a
novel cell type, which we have named Trx80-activated-monocytes
(TAMs). Trx80 activates monocytes and induces: i) up-regulation of
cell surface pathogen recognition receptors, such as CD14 (receptor
with a broad substrate specificity, stimulates phagocytosis of microbes
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and inhibits apoptosis), CD1a (associated to the recognition of lipids
and glycolipids by NK and T-cells) and Mannose Receptor (binds
certain carbohydrate moieties present on the surface of bacteria); ii)
up-regulation of molecules essential for T-cell activation and function,
such as CD86, CD54, CD40; iii) high pinocytic capacity; iv)
significantly higher release of the pro-inflammatory cytokines TNFa,
IL-1b and IL-6. Interestingly, Trx80 is the first bona fide cytokine
shown to induce production of the regulatory and anti-inflammatory
cytokines IL-12 and IL-10, respectively [12,13,14]. In this investiga-
tion we demonstrate that Trx80-activated monocytes are able to
control more efficiently the replication of intracellular bacteria by
preventing their escape from the endosomal compartments that will
further mature into a highly degradative phagolysosome.
Materials and Methods
Reagents
Recombinant Trx80 was prepared as described in detail earlier
[15]. Briefly, this protein was over-expressed in E. coli, where it was
found in inclusion bodies. Subsequently, Trx80 was solubilized
from these bodies utilizing urea and the resulting solution dialyzed
and subjected to ion-exchange and reverse-phase chromatogra-
phy, followed by gel filtration through a Sephadex G-75 column.
The purity of the final preparation was confirmed by SDS-
polyacrylamide gel electrophoresis. Finally, in order to eliminate
contamination by endotoxin, these Trx80 preparations were first
passed through a polymyxin B column and then in a positively
charged sterile filter. The endotoxin content was less than 0.2 ng/
ml in cell cultures exposed to 100 nM Trx80 as determined by the
Limulus amoebocyte lysate assay (Charles River Endosafe Inc.,
Charleston, S.C., USA). Stock solutions were maintained at
220u C until use. RPMI 1640 cell culture medium, L-glutamine,
penicillin and streptomycin (Gibco, BRL, Life technologies,
Paisley, Scotland); fetal calf serum (FCS, Hyclone, Logan UT);
LymphoprepTM (Axis-Shield PoC AS, Norway); trypan blue,
chloroquine, gentamicin solution, paraformaldehyde solution and
6-well ultralow cell culture attachment plates (Sigma, Chemical,
St. Louis, MO); CD14+ human microbeads (Miltenyi Biotec,
Friedrich-Ebert-Strabe, Germany); Lysotracker Red DND 99
and 2979-dichlorofluorescein diacetate (H2DCFDA, Molecular
probes); Vecta Shield mounting medium (Burlingame, CA); the
FITC mouse monoclonal antibodies anti-CD14 (APC; MØ´P9) and
the isotype antibody IgG2a (Becton Dickinson, San Diego, CA);
for bacterial culture media, brain heart infusion (BHI) broth, Luria
Bertani (LB) broth, and Bacto-Agar (Difco, France).
Purification of CD14+ cells
Human peripheral blood mononuclear cells (PBMC) were
prepared from the blood of healthy donors (Blood Bank, Karolinska
University Hospital) by the standard procedure of Ficoll-Paque
centrifugation, and viability was assessed by trypan blue exclusion.
Thereafter, monocytes were isolated using the CD14+ MACS
procedure, according to the manufacturer’s instructions and as
previously described [14]. Purified CD14+ cells were suspended in
complete RPMI 1640 medium containing 10% heat-inactivated
FCS, 2 mM L-glutamine, 100 U/ml penicillin and 100 micro-
grams/ml streptomycin (complete medium). Cells were seeded in 6-
well ultralow attachment plates, previously warmed at 37uC with
2 ml RPMI without serum. The use of human buffy coats was
approved by the ethics committee of the Karolinska Institutet.
Culture conditions and treatments
Following resuspension in complete medium at a concentration
of 106 cells per ml, CD14+ cells were cultured in the absence or
presence of 100 nM Trx80. All cells were cultured in a final
volume of 5–8 ml on 6-well ultralow attachment cell culture
plates, at 37uC with 5% CO2. For the inhibition of lysosomal
enzymes, chloroquine (10 mM) was added during the infection and
maintained throughout the experiment.
Flow cytometry analysis
Cell cultures were analyzed for CD14+ expression after 24 h
and 48 h in culture. Approximately, 56105 cells were incubated
with normal human serum for 30 minutes on ice to block Fc
receptors and reduce the non-specific binding of the monoclonal
antibodies (mAbs). The cells were incubated with FITC-conjugat-
ed CD14 mAb or the isotype-matched control IgG2a for 45
minutes on ice, washed once with 1 ml PBS and suspended in
500 mL of the same buffer. Thereafter, 104 cells were acquired on
a FACSCalibur flow cytometer (Becton Dickinson) and analyzed
using the CellQuest software (Becton Dickinson). As previously
described [14], the cell characteristic forward-scatter pattern was
used to generate a gate and only this population was analyzed.
Bacterial strains
The bacterial strains used were: Brucella abortus 2308, Listeria
monocytogenes strain EGD (BUG600, serotype 1/2a, kindly provided
by Dr. Martin E. Rottenberg), L. monocytogenes EGDe harbouring
the plasmid GFP-expressing pNF8 plasmid [16], L. monocytogenes
NF-L327, containing a transcriptional gene fusion actA-gfp-plcB,
that expresses GFP only when bacteria escape in the cytosol [17]
(kindly provided by Dr. Nancy E. Freitag). The Brucella strain was
routinely grown in LB medium, and the Listeria strains were grown
in BHI medium.
Monocyte infection and colony forming units (CFU) assay
CD14+ control monocytes and thioredoxin activated monocytes
(TAMs) were incubated with L. monocytogenes or B. abortus for 30
and 45 minutes, respectively at 37uC, 5% CO2. Cells were further
incubated for 1 hour in medium containing gentamicin 100 mg/
ml for elimination of extracellular bacteria (bacteria uptake). Cells
were washed once and maintained in RPMI containing 5 mg/ml
of gentamicin to prevent extracellular bacterial growth and re-
infection. After the infection, samples were taken at different time
points, cells were counted by trypan blue exclusion, washed once
with PBS and lysed with 0.1% Triton X-100 in PBS. Lysates were
prepared from 36105 viable cells, and 20 microliters aliquots were
plated on LB or BHI agar plates. Plates were incubated for
48 hours at 37uC and colony forming units (CFU) were quantified.
Listeria strains were used at a multiplicity of infection (MOI) of 25:1
or 50:1, and the Brucella experiments were performed at MOI of
100:1.
Immunofluorescence for detection of B. abortus
internalization
Extracellular bacteria were detected using a cow anti-Brucella
FITC conjugated antibody (1:150), added to 200 ml of infected
cells and incubated 30 minutes at 4uC under agitation. Cells were
washed with 1 ml PBS, centrifuged, resuspended in 200 ml PBS,
and transferred to slides to dry overnight at 37uC. Cells were then
fixed in 4% paraformaldehyde for 10 minutes at 22uC, and
incubated with ammonium chloride (50 mM) 10 minutes at 22uC,
blocked for 30 minutes at 22uC with human plasma and
permeabilized with 0.1% Triton X100 in PBS for 10 minutes.
Rabbit anti-Brucella antibodies diluted 1:200 in PBS containing
0.5% albumin were added and after incubation the slides were
washed twice with PBS and once with 0.1% Triton X100 in PBS.
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The cells were incubated for 30 minutes with an Alexa 568-
conjugated anti-rabbit secondary antibody, diluted 1:1000 in PBS
containing 0.5% albumin. This step allows to discriminate
between extracellular bacteria (labelled with both FITC and
Alexa 568-conjugated antibodies) and the intracellular bacteria
(labelled only with the Alexa 568-conjugated antibody). Slides
were washed as in the previous step. Nuclei were counterstained
with DAPI and mounted in glass slides with VectaShield mounting
medium (H1200). Slides were analyzed with a Leica DMRXA
fluorescence microscope with a CCD camera (Hammamatsu) and
images were captured with Improvision Openlab v.2 software.
LysoTracker staining
The acidification of Listeria containing phagosomes was
determined with the lysosomotropic agent LysoTracker red
DND-99 following the manufacturer’s instructions. After genta-
micin incubation LysoTracker red DND-99 was added to a final
concentration of 200 mM and maintained in the medium for the
indicated time. In non infected cells or cells infected with the GFP-
tagged Listeria were harvested and centrifuged at 2500 rpm for 5
minutes, washed 3 times with PBS 10% FBS (pre-warmed at 37uC)
and diluted to a final concentration of 86104–106104 cells/ml.
Aliquots of 70 ml were taken in triplicate, and spun at 200 rpm for
4 minutes (Cytospin 3, Shandon). Slides were fixed with freshly
prepared 4% paraformaldehyde for 15 minutes at 22uC, and
mounted in glass slides with VectaShield mounting medium
(H1200). Cover slides were analyzed by fluorescence microscopy
(Leica DMRXA fluorescence microscope). Colocalization of GFP-
labeled bacteria within lysotracker positive vesicles was assessed in
a minimum of 200 cells, from three independent slides by visual
analysis, and by correlation of the GFP and Lysotracker Red
fluorescence intensities using the Volocity software package
(Perkin Elmer). To detect the efficiency of bacterial escape from
the phagosome, cells infected with the L. monocytogenes strain NF-
L327 were spun and fixed as previously described. Slides were
analyzed by fluorescence microscopy (Leica DMRXA fluorescence
microscope).
Results
TAMs efficiently control intracellular replication of Listeria
monocytogenes
To assess whether Trx-80-activated monocytes contribute to
control replication of intracellular pathogens, we have chosen as
model L. monocytogenes, a bacterium that replicates in the cytosol of
infected cells. As previously demonstrated [12,13,14], TAMs
exhibited a 2- to 3-fold increase in the mean fluorescence intensity
for the surface marker CD14 after 24 and 48 hours stimulation
with 100 nM Trx80 compared to non-stimulated cells cultured in
medium alone (Figure 1). Therefore, the subsequent experiments
were performed with monocytes exposed to 100 nM Trx80 for
24 hours, and the levels of CD14 expression were routinely
assessed to confirm the efficacy of activation. Growth curve
kinetics demonstrated that the recovery of viable cells in infected
control monocytes or TAMs were similar (Figures 2A and 2B).
Time kinetic experiments demonstrated that TAMs limit
bacterial replication much more efficiently than control cells
24 hours post-infection, since the number of viable bacteria in
TAMs was less than 5% of that observed in control cells (Figure 3A).
The number of bacteria in TAMs remained significantly reduced up
to 48 hours post-infection (Figures 3A and 3B). We next investigated
whether the difference in bacterial recovery was due to reduced
entry in TAMs compared to control monocytes. To assess bacterial
uptake, control monocytes and TAMs were infected with L.
monocytogenes at MOI 25 for 30 minutes, and 100 mg/ml gentamicin
was added for 1 hour to kill the non-internalized bacteria. The rate
of uptake of L. monocytogenes was higher in TAMs compared to
control cells, as assessed by gentamicin assay (Figure 3B) or
immunofluorescence analysis (Figure 3C).
Figure 1. TAMs express high levels of CD14. Non-stimulated
monocytes and TAMs generated with Trx80 at 100 nM were analyzed
for CD14 expression after 24 and 48 hours in culture. MFI: mean
fluorescence intensity (mean 6 SEM of six independent experiments).
doi:10.1371/journal.pone.0016960.g001
Figure 2. Growth curve of untreated control monocytes and
TAMs after L. monocytogenes infection. Cells were infected as
described in Materials and Methods. After the infection, samples were
taken at the indicated periods of time, and number of viable cells was
assayed by trypan blue exclusion. The data are presented as number of
viable cells (panel A) and as percentage of cell recovery, being 100% of
recovery at time 0 (panel B). Mean6 SEM of six independent experiments.
doi:10.1371/journal.pone.0016960.g002
TAMs Control Bacterial Replication
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TAMs prevent the escape of L. monocytogenes from the
phagosome
We next investigated whether the lower level of bacterial
replication in TAMs was associated with reduced escape of L.
monocytogenes from the phagosome into the cytosol of infected cells.
As tool we used the NF-L327 strain, which expresses GFP upon
bacterial release into the cytosol [17]. Growth curves indicated
that uptake of the NF-L327 strain was similar in TAMs and
control cells, while a lower recovery of viable bacteria was detected
24 h after infection in Trx80-activated monocytes (Figure 4A).
These data correlated with the immunofluorescence analysis that
showed a 3- to 4-fold increase in the number of GFP-positive
bacteria in non-stimulated monocytes compared to that observed
in TAMs 8 hours after infection (Figures 4B and 4C), indicating
that L. monocytogenes NF-L327 was efficiently internalized and
trapped in the phago-lysosome upon Trx80-activation.
TAMs enhance L. monocytogenes compartmentalization
within acidified vesicles
The data presented in Figures 3 and 4 indicate that TAMs
internalize L. monocytogenes efficiently, prevent its escape into the
cytosol and exhibit enhanced bactericidal activity compared to the
non-stimulated cells. Since lysosomes represent one of the best-
characterized vesicles where activated monocytes exert their
bactericidal activity, we assessed whether Trx80 stimulation was
associated with an enhanced trapping of bacteria within the
lysosomal compartment, thus preventing escape into the cytosol.
Monocytes and TAMs were infected with a GFP-tagged Listeria at
MOI 50, and localization of the bacteria was assessed 4 hours
post-infection, using Lysotracker Red to visualize acidified
vacuoles. Uninfected control cells and TAMs presented similar
levels of lysosomal labeling (Figure 5A). In both cell types, infection
was associated with an increased number of Lysotracker Red
positive vesicles (Figures 5A and 5B). A 2- to 3-fold increase in the
number of bacteria within acidified compartments was observed in
TAMs, compared to non-stimulated monocytes 4 hours post-
infection (Figure 5B). The Volocity software was further used to
evaluate the co-localization between the GFP and the Lysotracker
Red fluorescence intensities. A correlation coefficient value of r2
equal to 1 indicates 100% of bacterial localization with the
lysosomal compartments; Figure 5C shows that TAMs have an r2
value of 0.9, while this is reduced to 0.6 in control cells.
Collectively, these results indicate that Trx80 activation retains L.
monocytogenes within acidified compartments and prevents bacterial
escape and replication in the cytosol.
Trx80-activated monocytes kill Listeria in the lysosomal
compartments
To investigate the role of lysosomal enzymes in TAM-induced
bactericidal activity on L. monocytogenes, we compared the effect of
chloroquine (10 mM) on bacterial recovery at 0 (uptake), 2 and
24 hours post-infection by gentamicin assays. Chloroquine
treatment enhanced the recovery of viable bacteria 24 hours after
infection in both cell types. However, the amount of viable
bacteria recovered in chloroquine treated TAMs was significantly
higher than that observed in non stimulated cells (Figure 6A).
Chloroquine treatment did not inhibit bacterial entry in control
cells or TAMs. On the contrary, we have observed an increased
recovery of L. monocytogenes in both cell types at time 0 (Figure 6B).
These data indicate that lysosomal-dependent degradation is a key
bactericidal mechanism induced by Trx-80 stimulation.
TAMs efficiently control intracellular replication of
Brucella abortus
We next assessed whether the effect of Trx80 on replication of
intracellular pathogens was dependent on the site of bacterial
replication, and we therefore have investigated the ability of
TAMs to control infection with Brucella abortus, a Gram negative
Figure 3. TAMs control replication of Listeria monocytogenes. A.
Intracellular growth curve of L. monocytogenes. Cells were infected for
30 minutes at 37uC with a multiplicity of infection of 25:1 bacteria per
cell, and medium containing 100 mg/ml gentamicin was added for 1 h
to kill extracellular bacteria (0 h). Cells were washed and RPMI
supplemented with 5 mg/ml gentamicin was added. At the indicated
periods of time, 36105 cells were lysed and colony forming units CFU
were quantified, as described in Materials and Methods. A representa-
tive experiment is shown. B. Summary of the growth curves of L.
monocytogenes. The data are presented as percentage of the number of
CFU recovered in TAMs relative to the number of CFU recovered in
control monocytes (mean 6 SEM of five independent experiments). C.
Cells were infected with L. monocytogenes for 30 minutes at 37uC with a
MOI 25:1 and medium containing 100 mg/ml gentamicin was added for
1 h to kill extracellular bacteria. Intracellular bacteria were detected by
immunofluorescence analysis as described in Materials and Methods
(mean 6 SEM of five independent experiments).
doi:10.1371/journal.pone.0016960.g003
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bacterium that replicates in the ER of infected cells. Control
monocytes and TAMs were infected with B. abortus at MOI 100:1
for 45 minutes, and 100 mg/ml gentamicin was added for 1 hour
to kill the non-internalized bacteria. As shown in Figure 7A, the
rate of uptake of B. abortus was more efficient in TAMs compared
to non-stimulated cells, as assessed by immunofluorescence
analysis. For long time kinetics, infected cells were maintained in
medium containing 5 mg/ml gentamicin, lysed at the indicated
times and the number of colony forming units (CFUs) was
evaluated after incubation for 48–72 hours at 37uC. The number
of viable bacteria was very low in the initial phase of the infection
in both cell types (Figure 7B). In control cells, the recovery of
bacteria steadily increased in a time-dependent manner up to
72 hours post-infection, while a significantly lower number of
CFUs was detected in TAMs at 24 hours post-infection, and this
was maintained up to 72 hours (Figures 7B and 7C).
Collectively these data indicate that Trx80 activation of
monocytes enhances their bactericidal activities and exerts an
efficient control of the infection by intracellular bacteria,
independently on the site of replication.
Discussion
Our findings shed new light on the role of thioredoxin (Trx) 80
as an effector molecule of the innate immune response against
intracellular pathogens. We have previously demonstrated that
Trx80 stimulates human monocytes to differentiate into a novel
cell type, Trx80-Activated-Monocytes (TAMs). TAMs have higher
pinocytic capacity, and enhanced secretion of pro-inflammatory
cytokines [14]. As these characteristics resemble those of activated
macrophages, we suggested that TAMs may play a major role in
the defense against intracellular pathogens [12,13,14]. In this
study, we performed a set of experiments to test this hypothesis.
We chose to focus on two intracellular pathogens known to survive
and replicate inside monocytes: Brucella abortus and Listeria
monocytogenes. To achieve their goal, they must interfere with the
different stages of phagosomal maturation to prevent their killing.
Phagocytosis of Brucella and Listeria is mediated by scavenger
receptors and functional lipid rafts [18,19]. Our findings show that
TAMs internalize Listeria with higher efficiency than non-
stimulated monocytes, since a higher number of bacteria was
Figure 4. Escape of L. monocytogenes NF-L327 into the cytosol of infected monocytes. A. Cells were infected with the L. monocytogenes
strain NF-L327, that expresses GFP when translocated into the cytosol, at MOI 50:1 for 30 minutes and medium containing 100 mg/ml gentamicin was
added for 1 h to kill extracellular bacteria (0 h). Cells were washed and maintained in RPMI supplemented with 5 mg/ml gentamicin. Cells were lysed
after infection (0 h) and 24 h in culture and the colony forming units CFU were quantified, as described in Figure 3A. A representative experiment is
shown. B. Cells were infected with the L. monocytogenes NF-L327 at MOI 50:1 as described in A and samples were taken 8 hours post-infection.
Cytospin and fluorescence imaging were performed as described in Materials and Methods. Bar represents 5 mm. C. Quantification of GFP-labeled
Listeria was performed using the Volocity software. The data are presented as number of bacteria in 200 cells (SEM of two independent experiments).
doi:10.1371/journal.pone.0016960.g004
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recovered from infected TAMs after the internalization step, as
assessed by gentamicin assays and immunofluorescence analysis
(Figure 3). This is in line with the enhanced phagocytic capacity of
TAMs [14]. Time kinetics of infection indicate that TAMs limit
Brucella and Listeria replication during the early/intermediate
stages of infection (Figures 3 and 6), which coincide with the
intermediate/late stages of phagosome maturation [1], neutraliz-
ing the strategies used by Brucella and Listeria to avoid phagolyso-
some-dependent degradation.
Listeria escapes the phagosome before it matures and fuses with
the lysosome. This step is very rapid, and occurs within five
minutes from the bacterial engulfment into the host cell, and it is
mediated by the production and secretion of listeriolysin O (LLO)
and two phospholipases, PI-PLC and PC-PLC. These enzymes
Figure 5. Localization of GFP-tagged L. monocytogenes in acidic compartments. A. Cells were infected with the GFP-tagged L.
monocytogenes at MOI 50:1 for 4 hours, and treated with the acidotropic dye Lysotracker Red. Cytospin centrifugation was performed and cells were
fixed with 4% paraformaldehyde. Lysotracker Red positive vesicles containing GFP-labeled bacteria are indicated with arrows. Bar represents 5 mm. B.
The percentage of Lysotracker Red positive vesicles containing GFP-labeled bacteria was quantified in two independent experiments. A minimum of
200 cells were analyzed. C. Scatter plot analysis showing the correlation between the GFP and Lysotracker Red fluorescence intensities in control cells
and TAMs quantified by the Volocity software. A correlation coefficient value of r2 equal to 1 indicates 100% bacterial localization with the lysosomal
compartments.
doi:10.1371/journal.pone.0016960.g005
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cause the breakdown of the membrane of the Listeria-containing
phagosome and thereby enable the bacteria to escape to the
cytosol where they replicate [1]. The data presented in Figures 4
and 5 indicate that more bacteria are localized within acidified
vesicles 4 hours after infection, resulting in 3- to 4- fold decreased
recovery of Listeria in the cytosol of infected cells. Trx80-dependent
activation may alter the environment of the phagosome preventing
activation of LLO and secretion of phospholipases. Maturation of
the phagolysosome per se may be accelerated upon cell activation
and bacteria can be killed with a faster kinetic. Alternatively,
Trx80 activation may enhance the autophagy process, resulting in
formation of autophagosomes [20]. Similar results have been
reported in macrophages activated with IFN-c or LPS [21],
indicating that at least for the control of Listeria replication, Trx80
activation has similar effects as other well-known activators of the
macrophage function. It has been previously shown that reduction
of LLO is required to activate its lytic activity and this is achieved
by the enzyme c-interferon-inducible lysosomal thiol reductase
(GILT, also called Ifi30) [22]. It is unlikely that Trx80 contributes
to this process, since it lacks the disulfide oxidoreductase activity
and Trx80 stimulation of monocytes in absence of T lymphocytes
is not sufficient to induce IFN–c production and secretion [12].
Survival of Brucella inside the cell relies on avoiding fusion of the
Brucella-containing vacuole (BCV) with lysosomes. For its intracel-
lular survival, Brucella produces cyclic glucans and requires the
type IV secretion system VirB. Cyclic glucans modulate
maturation of BCV to avoid fusion with lysosomes [23], while
VirB is required for the late BCV maturation events correspond-
ing to sustained interaction and fusion with the ER [4]. TAMs
could act either by neutralizing the cyclic glucans at the early stage
of the infection or interfering with the VirB system to prevent
fusion of the BCV with the ER.
The last step in phagosomal maturation is the fusion of the
phagosome with the lysosome that culminates in the formation of
the phagolysosome [1]. Our experiments show a higher recovery
of viable bacteria in chloroquine-treated TAMs 24h post-infection
compared to chloroquine treated non-stimulated cells (Figure 6).
These data are in agreement with the results presented in Figures 3
and 4, which showed a higher uptake of bacteria and an enhanced
localization of the GFP-tagged L. monocytogenes in acidic compart-
ments as early as 4 hours after infection in TAMs, and indicate
that lysosomal degradation is one of the main bactericidal
mechanisms induced by Trx-80 activation in monocytes.
Many pathogens have evolved several strategies to escape the
host’s innate and adaptive immune responses [24]. Therefore it
would not be surprising if bacteria could overcome the Trx80-
induced monocyte activation. It was recently reported that the
Salmonella type III secretion factor (SIrP) is an E3 ubiquitin ligase
Figure 6. Increased recovery of L. monocytogenes in cells treated with the lysosomotrophic agent chloroquine. Control monocytes and
TAMs were infected with L. monocytogenes EGD strain at MOI 25:1 for 30 minutes in the absence or presence of chloroquine (10 mM) and the
treatment was maintained throughout the experiment. A. At the indicated periods of time, cells were lysed and the CFU quantified as described in
Figure 3A. Results are shown as ratio between the number of CFU recovered in chloroquine treated cells and the number of CFU recovered in non-
treated cells at each time point. B. Number of CFU at time 0 h.
doi:10.1371/journal.pone.0016960.g006
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that can mediate ubiquitination of human thioredoxin, reducing
the levels of Trx and rendering the cells more prone to cell death
[25]. The strategy of bacteria like Salmonella to decrease the levels
of Trx will directly affect the production of Trx80, and
consequently impair the TAMs-mediated immune response.
The production of Trx80 in vivo is not fully understood;
however, several reports indicate that activated monocytes are the
main producers of Trx80 [26,27,28]. The most likely mechanism
is that full-length Trx is cleaved at the protein level by an inducible
protease to generate Trx80. Isolated monocytes from healthy
donors cleave exogenously added Trx to the truncated form within
1 min after addition of full-length Trx. Upon cleavage of Trx, the
truncated species adhere to the membrane of macrophages [29].
In vitro established T, B and monocytic cell lines produce Trx80,
whereas isolated T and B lymphocytes and monocytes produce
Trx80 in minimal amounts. However, when PBMC or isolated
monocytes are exposed to cytokines (IFN-c, IL-1a), bacterial
products (fMLP, LPS, ionomycin) or mitogens (Phorbol myristate
acetate, Concanavalin A, pokeweed mitogen, phytohemagglutinin)
the production of Trx80 is increased [26,27,28].
Does production of Trx80 have a role in vivo? Up to now there
are no data regarding the efficacy of this protein in controlling
replication of intracellular bacteria in vivo. However, Trx80 is
detected in plasma of healthy blood donors in concentration up to
20 nM [15]; and functional assays show increased levels of Trx80
in patients with severe schistosomiasis [8] and patients affected by
chronic inflammatory conditions, such as rheumatoid arthritis
[30]. These data indicate that Trx80 is produced in physiological
conditions, and that its production/secretion is increased in
pathologies associated with chronic inflammation. Local concen-
trations of Trx80 in health or disease (infection/inflammation)
should be much higher than the reported in plasma, therefore our
experimental settings (100 nM) should be within the range at the
site of cell production. Thus, at the site of infection/inflammation,
cells can be induced to produce full-length Trx and/or Trx80,
whose chemoattractant properties could result in recruitment of
polymorphonuclear neutrophils, T cells and monocytes
[11,28,31]. These monocytes can cleave full-length Trx to
Trx80, as well as produce their own Trx80 [28,29]. This situation
would then lead to activation of the monocytes by Trx80, up-
regulating expression of pattern recognition receptors (CD1a,
CD14, MR), receptors for communication with T or NK cells
(CD40, CD54, CD86) and the release of cytokines and
chemokines (TNFa, IL-1b, IL-6 and IL-8). Cross-talk between
TAMs and T cells will stimulate the TAMs to produce IL-12,
which in turn, will subsequently trigger the production of IFN-c by
the T lymphocytes [12,13,14].
In conclusion, we have demonstrated that Trx80 possesses an
intrinsic capacity to control intracellular infections, and that
TAMs are effective against bacteria, such as B. abortus and L.
monocytogenes. The effects of Trx80 on monocytic cells are similar to
those induced by IFN-c, which plays a mandatory role in
protection against intracellular pathogens. These data suggest
that TAMs are efficient effectors of the innate immune response
and represent a first line of defense against intracellular infections,
before the immune system can mount a proper T-cell response.
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